Linfoma primario tiroideo. A propósito de un caso

  1. Herranz-Antolin, Sandra
  2. Vázquez-Ramo, Alejandro 1
  3. Serrano-Martínez, Alberto 2
  4. Benito-López, Dulce 3
  5. Álvarez-de Frutos, Visitación 4
  1. 1 Sección de Hematología y Hemoterapia, Hospital Universitario de Guadalajara, Guadalajara, España
  2. 2 Sección de Medicina Interna, Hospital Universitario de Guadalajara, Guadalajara, España
  3. 3 Servicio de Anatomía Patológica, Hospital Universitario de Guadalajara, Guadalajara, España
  4. 4 Sección de Endocrinología y Nutrición, Hospital Universitario de Guadalajara, Guadalajara, España
Show affiliations +
Journal:
Revista Española de Casos Clínicos en Medicina Interna (RECCMI)

ISSN: 2530-0792

Year of publication: 2017

Issue Title: Spanish Journal of Case Records in Internal Medicine

Volume: 2

Issue: 3

Pages: 125-127

Type: Article

DOI: 10.32818/RECCMI.A2N3A8 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Revista Española de Casos Clínicos en Medicina Interna (RECCMI)

Abstract

Primary thyroid lymphoma is a rare entity that should be suspected in women who present a rapid growth of the thyroid gland with compressive cervical symptoms. Surgery has a mainly diagnostic utility and systemic chemotherapy with or without radiotherapy is the treatment of choice in these cases. We present the case of a woman with a primary thyroid B cell type non-Hodgkin lymphoma intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.

Bibliographic References

  • Watanabe N, Noh JY, Narimatsu H, Takeuchi K, Yamaguchi T, Kameyama K, et al. Clinicopathological features of 171 cases of primary thyroid lymphoma: A long-term study involving 24,553 patients with Hashimoto’s disease. Br J Haematol. 2011; 153: 236-243.
  • Walsh S, Lowery AJ, Evoy D, McDermott EW, Prichard RS. Thyroid lymphoma: Recent advances in diagnosis and optimal management strategies. Oncologist. 2013; 18: 994-1003.
  • Waish S, Lowery AJ, Evoy D, McDermott EW, Prichard RD. Thyroid lymphoma: recent advances in diagnosis and optimal management strategies. Oncologist. 2013; 18: 994-1003.
  • Huang YC, Kim TY, Kim WB, et al. Clinical characteristics of primary thyroid lymphoma in Koreans. Endocr J. 2009; 56: 399-405.
  • Graff-Baker A, Roman SA, Thomas DC, Udelsman R, Sosa JA. Prognosis of primary thyroid lymphoma: demographic, clinical and pathologic predictors of survival in 1408 cases. Surgery. 2009; 146: 1105-1115.
  • Treglia G, Del Ciello A, Di Franco D. Recurrent lymphoma in the thyroid gland de- tected by fluorine-18-fluorodeoxyglucose PET/CT. Endocrine. 2013; 43: 242-243.
  • Graff Baker A, Ann Sosa J, Roman SA. Primary thyroid lymphoma: a review of recent developments and histology-driven treatments. Curr Opin Oncol. 2010; 22: 17-22.
  • Watanabe N, Narimatsu H, Noh JY, Kunii Y, Mukasa K, Matsumoto M, et al. Rituximab-Including Combined Modality Treatment for Primary Thyroid Lymphoma: An Effective Regimen for Elderly Patients. Thyroid. 2014; 24: 994-999.
  • Onal C, Li YX, Miller RC, Poortmans P, Constantinou N, Weber DC, et al. Treatment results and prognosis factors in primary thyroid lymphomas: A rare cancer network study. Ann Oncol. 2011; 22: 156-164.
Data source: Dialnet